· If you or a loved one has been diagnosed with Alzheimer's disease, or a physician suspects it may be Alzheimer's disease, you or they may be eligible to participate in a clinical research study.
Criteria:
To be considered for the RefocusALZ study, patients must:
Ages 50 to 87 years old
Be diagnosed with, or have a suspected clinical diagnosis of, Alzheimer’s Disease
Have a gradual change in memory for six months or more
Have a family member or loved one who can be available as a study partner during the entire study
Be fully vaccinated for COVID-19 or have had a previous COVID-19 infection
Other criteria will apply.